| Phase 1 | 1 | |
| Phase 1/2 | 2 | |
| Phase 2/3 | 1 | |
| Phase 3 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07770828 | Phase 3 Study to Assess Efficacy, Safety & Tolerability of OCU410 For Geographic Atrophy… | Dry Age-related Macular Degeneration | Recruiting | 2026-08-19 |
| NCT06388200 | A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa | Retinitis Pigmentosa | Active, Not Recruiting | 2026-07-31 |
| Phase 2/3 | ||||
| NCT05956626 | A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease | Stargardt Disease | Active, Not Recruiting | 2026-07-31 |
| Phase 1/2 | ||||
| NCT05203939 | Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber… | Retinitis Pigmentosa | Active, Not Recruiting | 2026-07-31 |
| NCT06018558 | Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy | Geographic Atrophy | Active, Not Recruiting | 2026-07-31 |
| Phase 1 | ||||
| NCT05802329 | Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic… | Center Involved Diabetic Macular Edema | Recruiting | 2026-07-31 |